InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-19.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kumar Ramesh, Director. Officer active across 1 company, notably Ocugen, Inc.. In total, 9 filings have been logged. Activity tracked since 19 July 2021. The latest transaction was filed on 6 October 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations9 total
4,500 shares@ US$0.518.0% of flowCommon StockSEC:0001062993-22-020658:0
7,500 shares@ US$0.5112.8% of flowCommon StockSEC:0001062993-22-016559:0
7,500 shares@ US$0.510.0008% mcap15.2% of flowCommon StockSEC:0001062993-22-010494:0
7,500 shares@ US$0.5111.4% of flowCommon StockSEC:0001062993-22-001294
7,500 shares@ US$0.510.0008% mcap14.4% of flowCommon StockSEC:0001062993-22-001294:0
7,500 shares@ US$0.510.0008% mcap14.1% of flowCommon StockSEC:0001879785-21-000009:0
7,500 shares@ US$0.5111.2% of flowCommon StockSEC:0001879785-21-000009
7,500 shares@ US$0.5111.0% of flowCommon StockSEC:0001192482-21-000636
7,500 shares@ US$0.510.0008% mcap13.9% of flowCommon StockSEC:0001192482-21-000636:0
9 of 9 declarations
About Kumar Ramesh
Kumar Ramesh is a Board Member at Ocugen, Inc., a company focused on developing gene therapies and treatments for eye diseases. With expertise in the biopharmaceutical sector, he contributes to the strategic direction of the company. His role involves overseeing operations and making key decisions for the organization's growth.
